2019 - Pandemic 2020 - False election 2021 - Vaccine 2022 - War 2023 - Biggest inflation 2024 - TRUMP’S BIG COMEBACK! 2025 - Peace in the world! #SHARE if you agree! JOIN 👇 https://t.me/+Q5Z374XfX_IxYTE1

BASTARDI SENZA GLORIA NE' FUTURO! Un anno fa, Julia suonava il pianoforte nella sua casa a Khiam, nel sud del Libano. Oggi i soldati israeliani si filmano mentre giocano tra le rovine della sua casa. Prima dell'inizio della guerra in Libano, questa donna libanese, Julia, ha condiviso un video mentre suonava il pianoforte a casa sua. Qualche giorno fa ha scoperto le foto della sua casa, distrutta e bruciata, nei post condivisi dai soldati israeliani! Julia Ali: “La mia casa a Khiam (nel sud del Libano). Anni di ricordi, anni trascorsi a suonare questo pianoforte. Il mio cuore è a pezzi". MA VOI STATE TRANQUILLI! NON SONO TUTTI UGUALI! 😂😂😂 BASTARDS WITHOUT GLORY OR FUTURE! A year ago, Julia was playing the piano in her home in Khiam, southern Lebanon. Today, Israeli soldiers film themselves playing in the ruins of his house. Before the war began in Lebanon, this Lebanese woman, Julia, shared a video of herself playing the piano in her home. A few days ago he discovered photos of his house, destroyed and burned, in the posts shared by Israeli soldiers! Julia Ali: “My house in Khiam (southern Lebanon). Years of memories, years spent playing this piano. My heart is broken." BUT YOU ARE QUIET! THEY ARE NOT ALL THE SAME! Fonte: https://t.me/lanuovanormalita #gaza #freegaza #freepalestine #lebanon #freelebanon

Tricarico uno di noi!!! MASSIMA DIFFUSIONE! https://youtu.be/bR17Shs_NdA?feature=shared

CAR T Cell Therapy Market Emerging Trend, Opportunities, Key Players, Huge Growth, Revenue Analysis, 2023-2035 The latest report entitled ‘CAR T Cell Therapy Market’ by Roots Analysis provides an accurate estimation of the market size, regional landscape description, and revenue forecast over the projected timeframe. The current global CAR T-cell therapy market size is likely to be worth USD 4.6 billion, and is projected to reach worth USD 15.2 billion by 2035, growing at a CAGR of 11.4% during the period, till 2035. The report turns the spotlight on the major challenges faced by the key players in the global market and the growth strategies currently adopted by them. The report is a granular assessment of this particular business sphere and entirely covers the dynamic competitive landscape of the market. The document offers key insights into the market positions of these players alongside their gross earnings. Furthermore, it elaborates on each of the market segments, with detailed scrutiny of the development scope and competitive scenario of the regional fragments of the market. The latest study is inclusive of an in-depth analysis of the economic status of the CAR T Cell Therapy Market and examines the most important regions constituting the global market. It further details on the most lucrative and growth-oriented regions, top market rivals, diversified product types, and a large number of end-use industries. Key factors affecting the growth of the CAR T Cell Therapy Market: Geographical Overview: • The latest report broadly categorizes the CAR T Cell Therapy Market into several geographical terrains, including North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa and Rest of the World. • The study is inclusive of essential information relevant to each region in this broad industry segment, along with the key drivers of the regional market growth. • The report further estimates the revenue accumulated by these regions over the forecast period. Competitive Hierarchy: • The latest research report studies the major market players, their regional presence, industry share, and production facilities. • The report offers significant data pertaining to these market competitors’ company profiles, product types, and application outlook. • Moreover, the pricing models and gross margins of these industry majors have also been mentioned in the report. Key players Autolus, Bluebird Bio, Bristol Myers Squibb, Carsgen Therapeutics, Cellectis, Gilead Sciences, Innovative Cellular Therapeutics, Noile-Immune Biotech, Novartis, Shanghai GeneChem, Sinobioway Cell Therapy, Takara Bio and Wellington Zhaotai Therapies. Additional parameters of the CAR T Cell Therapy Market report: • The latest research study endows the reader with a comprehensive analysis of the product types of the CAR T Cell Therapy Market, categorizing the relevant information into the Distribution by Target Inidcation, Target Antigens and Key Geographical Regions. The study focuses on the wide-ranging application landscape of the market, segmenting it into the market share, estimated growth rate, and the forecast product demand for each application type. Additional Insights: • The market concentration rate and processing rate of raw materials have also been conscripted in the report. • The report contains an assessment of the current price trends, as well as the factors influencing the global market size. • It throws light on the significant marketing strategies implemented by the eminent players in the industry. • Vital data and information concerning the producers, distributors, and downstream buyers involved in the global market, as well as the cost structure analysis and market mechanism, form the important elements of this report. Research objectives: • The CAR T Cell Therapy Market report studies the worldwide market consumption rate in terms of value and volume. • It identifies the various sub-segments of the market structure. • It proffers information regarding the leading global manufacturers in this industry, describing their market value & share, sales volume, competitive analysis, SWOT analysis, and development strategies adopted during the forecast timeline. • The report describes the key industry players, with respect to their individual growth trends, future prospects, and contribution to the global market, and explains the factors related to their market growth potential, drivers, opportunities, threats, and industry-specific challenges. • Furthermore, the report underpins the strategic developments occurring in the CAR T Cell Therapy Market, such as expansions, mergers & acquisitions, agreements, as well as new product launches. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/car-t-cell-therapy-market/269.html About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way. The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide. Contact: Roots Analysis +1 (415) 800 3415 Sales@rootsanalysis.com

VACCINI, DOMANDE DA SÌ/NO CON FRAJESE ▷ "FU BUGIA DI STATO. PRESTO PREPARATIVI PER UN NUOVO ROUND?" Che ne è stato dei lockdown, delle mascherine, dei tamponi? Quella che per molti è un'era già buttata dietro le spalle è ancora nelle indagini e negli studi di tutto il mondo. Anche in Italia una commissione d'inchiesta esaminerà gli eventuali errori commessi nella gestione dell'emergenza pandemica da Sars-CoV-2, mentre si fa spazio la possibilità delle già annunciate "future pandemie". scrizione VACCINI, DOMANDE DA SÌ/NO CON FRAJESE ▷ "FU BUGIA DI STATO. PRESTO PREPARATIVI PER UN NUOVO ROUND?" Che ne è stato dei lockdown, delle mascherine, dei tamponi? Quella che per molti è un'era già buttata dietro le spalle è ancora nelle indagini e negli studi di tutto il mondo. Anche in Italia una commissione d'inchiesta esaminerà gli eventuali errori commessi nella gestione dell'emergenza pandemica da Sars-CoV-2, mentre si fa spazio la possibilità delle già annunciate "future pandemie". "Rendiamoci conto di che cosa è veramente successo", dice il dott. Giovanni Frajese in diretta. "Anche perché sennò rischiamo di ricominciare da capo a dodici. La prossima pandemia? Ci hanno già avvisato in tutte le salse che questo accadrà. Mi sembra che a ottobre ci sia questa nuova simulazione per una pandemia da H5N1, da aviaria. Sapendo che hanno fatto l'evento 201 nel 2019 - simulazione del Johns Hopkins Centre for Health Security avvenuta il 18 ottobre 2019 a New York (in collaborazione con la fondazione di Bill Gates), ndr - simulazione che immaginava una futura pandemia da coronavirus, non vorrei che fossero i preparativi per il nuovo round" https://youtu.be/kPwDYP6tNCw?feature=shared

"Milano come vuoi tu". Oppure: "Perfetto stile neomilanese". Cascina Merlata, vecchio quartiere del capoluogo lombardo diventato oggi il simbolo di un nuovo modo di abitare. Appartamenti di ogni dimensione, garage personale, niente... https://www.raiplay.it/video/2024/10/Milano-lurbanistica-della-solitudine---PresaDiretta-20102024-1200b9a9-3049-4e10-995f-937660147173.html?wt_mc=2.www.share.raiplay_vid_Presadiretta

Elon Musk wasted no time going straight into politics and the 2024 election. He broke his silence on his deleted tweet about Kamala Harris, explaining that nobody even bothers trying to assassinate Kamala Harris because she's just another "puppet" of the "machine." “Nobody tries to assassinate a puppet,” Musk said. “She's safe,” he continued. “Like, they tried to kill Trump twice with actual guns and bullets.” Musk went on to explain that Trump inherently has the "constitution of an ox,” even though he doesn't work out and consumes “cheeseburgers and Diet Coke and stuff.” “I think he [Trump] just inherently has a strong constitution,” Musk said, adding that he is of “sound mind and body and strong backbone” after two assassination attempts. SHARE IF YOU SUPPORT REAL JOURNALISM WITHOUT CENSORSHIP! Elon Musk non ha perso tempo e si è lanciato subito nella politica e nelle elezioni del 2024. Ha rotto il silenzio sul suo tweet cancellato su Kamala Harris, spiegando che nessuno si preoccupa nemmeno di provare ad assassinare Kamala Harris perché è solo un'altra "burattina" della "macchina". "Nessuno prova ad assassinare una burattina", ha detto Musk. "È al sicuro", ha continuato. "Tipo, hanno provato ad uccidere Trump due volte con pistole e proiettili veri". Musk ha continuato spiegando che Trump ha intrinsecamente la "costituzione di un bue", anche se non si allena e consuma "cheeseburger e Diet Coke e roba del genere". "Penso che lui [Trump] abbia semplicemente una costituzione intrinsecamente forte", ha detto Musk, aggiungendo che è "sano di mente e corpo e ha una spina dorsale forte" dopo due tentativi di assassinio. CONDIVIDI SE SUPPORTI IL VERO GIORNALISMO SENZA CENSURA! JOIN👇 https://t.me/+YlsXJRGpdG0wMmY1

Roger Waters- Stand up for Palestine Empathy or Genocide make a choice. Streamed live on Double Down News -- 18:30 GMT Friday 21 June https://youtu.be/vob6SkI0R2E?feature=shared

The competitive environment is a crucial element that every key factor needs to be aware of. The study explains the market's competitive landscape so that readers may gauge the degree of both domestic and global rivalry. Additionally, market researchers have provided summaries of each significant firm in the global Medical Imaging industry, taking into consideration crucial elements including operational areas, production, and product portfolio. When analyzing the organizations in the study, significant factors including business size, market share, market growth, revenue, production volume, and profitability are also taken into account. The study report uses both qualitative and quantitative data to offer a thorough view of the market. It examines and forecasts the global market in a number of critical industries. The research provides a thorough overview of the industry by segmenting the Medical Imaging market into groups based on application, end-user, and location. A thorough research of each market segment was conducted, taking into consideration current and upcoming market trends. Global Medical Imaging Market was valued at USD 38.2 billion in 2022 and is expected to rise from USD 40 billion in 2023 to reach a value of USD 60.0 billion by 2031, at a CAGR of 5.2% during the forecast period (2024–2031). Chance to get a free sample @ https://www.skyquestt.com/sample-request/medical-imaging-market

Fill-finish Pharmaceutical Contract Market Global outlook 2024 to 2031 | Skyquest Leading market research firm SkyQuest Technology Group recently released a study titled 'Fill-finish Pharmaceutical Contract Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Fill-finish Pharmaceutical Contract report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Fill-finish Pharmaceutical Contract Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis. The research analysis on the global Fill-finish Pharmaceutical Contract Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Fill-finish Pharmaceutical Contract Market circumstances in the forecast period between 2024 and 2031. The global Fill-finish Pharmaceutical Contract Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Fill-finish Pharmaceutical Contract Market has experienced robust growth over the past decade and is projected to continue expanding. In 2022, the global fill-finish pharmaceutical contract manufacturing market reached a significant value of USD 8.1 billion. Projections indicate that this market is poised for steady growth, with an estimated compound annual growth rate (CAGR) of 6.1% expected from 2024 to 2031. This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure. Chance to get a free sample @ https://www.skyquestt.com/sample-request/fill-finish-pharmaceutical-contract-manufacturing-market Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Fill-finish Pharmaceutical Contract Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs. By Product Type - Prefilled Syringes, Vials, Cartridges, Others By Molecule Type - Large Molecules, Small Molecules By End-user - Biopharmaceutical Companies, Pharmaceutical Companies By Region - North America, Asia Pacific, Latin America, Europe Get your customized report @ https://www.skyquestt.com/speak-with-analyst/fill-finish-pharmaceutical-contract-manufacturing-market Following are the players analyzed in the report: AbbVie Inc. Boehringer Ingelheim Pfizer Catalent Inc Recro Pharma, Inc. Baxter’s BioPharma Solutions Eurofins Scientific Symbiosis Pharmaceutical Service MabPlex International Co. Ltd. Recipharm AB Fresenius Kabi Contract Manufacturing Novartis Regional Analysis 1. North America: - The United States and Canada dominate the North American Fill-finish Pharmaceutical Contract Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Fill-finish Pharmaceutical Contract consumption. 2. Europe: - Europe is a significant player, with major Fill-finish Pharmaceutical Contract Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Fill-finish Pharmaceutical Contract manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Fill-finish Pharmaceutical Contract Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Fill-finish Pharmaceutical Contract Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development. Buy your full report: https://www.skyquestt.com/buy-now/fill-finish-pharmaceutical-contract-manufacturing-market